Literature DB >> 15561979

The Jak-STAT pathway stimulated by interferon alpha or interferon beta.

Curt M Horvath1.   

Abstract

Type I interferons, such as interferon alpha and interferon beta (IFN-alpha and beta), signal through a Janus kinase (Jak) to signal transduction and activator of transcription (STAT) pathway to stimulate gene expression. In response to ligand binding, the receptors dimerize, Jaks phosphorylate STAT1 and STAT2, which then dimerize and interact with a third transcriptional regulator IFN regulatory factor 9 (IRF9) to stimulate gene expression. IFN-alpha is the main innate antiviral cytokine and is essential for effective immune response to viral infection. The animation shows activation of STAT-responsive gene expression in response to type I IFNs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561979     DOI: 10.1126/stke.2602004tr10

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  24 in total

1.  Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection.

Authors:  Joseph Ignatius Irudayam; Deisy Contreras; Lindsay Spurka; Aparna Subramanian; Jenieke Allen; Songyang Ren; Vidhya Kanagavel; Quoclinh Nguyen; Arunachalam Ramaiah; Kalidas Ramamoorthy; Samuel W French; Andrew S Klein; Vincent Funari; Vaithilingaraja Arumugaswami
Journal:  Stem Cell Res       Date:  2015-08-15       Impact factor: 2.020

Review 2.  The innate immune playbook for restricting West Nile virus infection.

Authors:  Kendra M Quicke; Mehul S Suthar
Journal:  Viruses       Date:  2013-10-30       Impact factor: 5.048

3.  Ipr1 Regulation by Cyclic GMP-AMP Synthase/Interferon Regulatory Factor 3 and Modulation of Irgm1 Expression via p53.

Authors:  Fayang Liu; Hongni Xue; Jie Ke; Yongyan Wu; Kezhen Yao; Shuxin Liang; Aihua Xu; Yong Zhang
Journal:  Mol Cell Biol       Date:  2020-03-30       Impact factor: 4.272

4.  RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2.

Authors:  Akihiko Komuro; Curt M Horvath
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

5.  Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signaling.

Authors:  Lei Zhang; Qiaoling Song; Xinxin Zhang; Li Li; Ximing Xu; Xiaohan Xu; Xiaoyu Li; Zhuoya Wang; Yuxi Lin; Xin Li; Mengyuan Li; Fan Su; Xin Wang; Peiju Qiu; Huashi Guan; Yu Tang; Wenfang Xu; Jinbo Yang; Chenyang Zhao
Journal:  Invest New Drugs       Date:  2019-05-14       Impact factor: 3.850

Review 6.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

Review 7.  Innate immune evasion by hepatitis C virus and West Nile virus.

Authors:  Brian C Keller; Cynthia L Johnson; Andrea Kaup Erickson; Michael Gale
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-16       Impact factor: 7.638

Review 8.  Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma.

Authors:  Lakshminarayanan Nandagopal; Gurudatta Naik; Guru Sonpavde
Journal:  Curr Treat Options Oncol       Date:  2018-01-18

9.  Lipopolysaccharide induces CD38 expression and solubilization in J774 macrophage cells.

Authors:  Cha-Uk Lee; Eun-Kyung Song; Chae-Hwa Yoo; Yong-Keun Kwak; Myung-Kwan Han
Journal:  Mol Cells       Date:  2012-11-23       Impact factor: 5.034

Review 10.  N6-Methyladenosine Regulates Host Responses to Viral Infection.

Authors:  Michael J McFadden; Stacy M Horner
Journal:  Trends Biochem Sci       Date:  2020-12-09       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.